PBAC submission to the Senate Inquiry into the availability of new, innovative and specialist cancer drugs in Australia
Page last updated: 15 April 2015
The Pharmaceutical Benefits Advisory Committee (PBAC) has provided a submission to the Senate Inquiry on the availability of new, innovative and specialist cancer drugs in Australia.
